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Selective Recovery of 13-Galactosidase With Charged Fusion Tails 
Using Ion-Exchange Membranes 
ERIKA A. THIEM and MENG H. HENG 
Department of Chemical Engineering, 231 Sweeney Hall, Iowa State University, Ames, IA 50011 
We explored the feasibility of attaching charged tails to a target protein, in this case (3-galactosidase, for selective recovery. In this 
process, an ion-exchange membrane was used for selective binding and release of (3-galactosidase with the attached purification fusions. 
Strength of binding and purity of eluate increased with increasing tail length. In addition, activity yield was improved with the imple-
mentation of an intermediate partial elution recycle procedure. 
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The ability to generically manipulate proteins has made it possible 
to mass produce those of interest. This breakthrough has lead to many 
technological advancements in science and industry. However, prob-
lems arise when genetically engineered proteins need to be separated 
and purified. The cost associated with separating and purifying pro-
teins to the standard of industrial use is a major production cost. In 
fact, purification and recovery costs can account for as much as 80 per-
cent of the total manufacturing cost in the large-scale production of 
recombinant protein products (1). Thus, without new downstream 
processing techniques, the abundance of genetically engineered pro-
teins may lead to little profitability. 
In an effort to keep pace with modern technology, new procedures 
are being developed for downstream processing in the areas of separa-
tion and purification. Ion-exchange is a technique which has been in 
use for many years. The bind and release process allows proteins with 
a certain ionic charge to be separated from others having the opposite 
charge or no charge. Recent developments in biotechnology utilize 
genetically engineered proteins in ion-exchange procedures, in partic-
ular proteins with attached purification fusions. Purification fusions 
enhance selectivity of ion-exchange operations as well as facilitate dif-
ficult separations. In designing fusion "rails", additional charges sup-
plied by charged amino acids are used to provide the fusion with a 
distinctive charge which readily facilitates purification. The fusion 
protein is made by combining the DNA of the target protein with 
DNA coding for the fusion tail. The result is the expression of the 
fusion tail in the target protein. 
For this work, a microporous membrane was selected as the ion-
exchange vehicle for application with the purification fusions. 
Previous research in our laboratory has taken advantage of negatively-
charged fusion proteins in examining other ion-exchange separation 
techniques (2,3). Cationic polyelectrolyte precipitation and aqueous 
two-phase extraction are two separation methods in which increased 
selectivity in separation was seen with the purification fusions. The 
decision to explore ion-exchange membranes for selective separation 
was based on its low cost, ease of use, and scale-up potential. The 
membrane provided a uniform matrix that allowed rapid binding 
kinetics without problems of diffusion or flow problems common 
with packed bed or chromatographic separations. 
The membrane was used in studying a model protein separation 
system where 13-galacrosidase was recovered from cell extracts pre-
BGCDl 
BGCD5 
BGCDll 
... Gin Lys I Gly Asp Pro Met Ala Tyr 
... Gin Lys I Gly Asp Pro (Asp)4 Ser Tyr 
... Gin Lys I Gly Asp Pro (Asp)10 Ser Tyr 
Fig. 1 Amino Acid Sequences for Purification Fusions. 
pared with fusion tails. Prior research (4) has shown success in the use 
of purification fusions to enhance selectivity using hollow fiber ion-
exchange membranes (HFIEM). Over six fold enrichment was 
observed when the HFIEM was used for ion-exchange. Similar results 
were expected with the ion-exchange membrane cartridge. 
MATERIALS AND METHODS 
Fermentation and Extraction 
The fusion tails were produced from Escherichia coli strain Yl089-l 
with coding for 13-galactosidase. The fusion tails were attached at the 
carboxyl terminus of the 13-galactosidase and consisted of a series of 
amino acids with asparrates supplying the negative charge. Three 
purification fusions of various lengths; BGCDl, BGCD5 and 
BGCDl 1 had been prepared previously (5). BGCDl was used as a 
control and contained one additional asparrate due to the restriction 
sire. Four more aspartates were fused to BGCD5 and 10 more to 
BGCDl 1. Figure 1 shows the specific sequences for each purification 
fusion tail. From typical pK values for amino acids in proteins, net 
charges of the fusion tails were estimated to be -22.48, -37.72 and 
-60.57 for BGCDl, BGCD5 and BGCDl 1 respectively with the 
wild type having a net charge of-18.4. A cleavage site exists between 
the first aspartate in the chain and praline to allow for removal of the 
tail. Tyrosine allows for ultraviolet detection. 
The cells were grown in Luria-Bertani medium and fermented for 
8 to 9 hours in an environmental shaker (37°C and 100 rpm). The 
cells were then harvested by centrifugation (4°C and 15000 g). After 
10 minutes of centrifugation, the cells were washed with a neutral 
Tris-HCl buffer and recentrifuged. At this stage the cells were stored 
at -70°C until ready for use. 
The cell walls were ruptured by sonicarion (Heat Systems Wl85 
Sonifier, Ultrasonics Inc., Plainview, NY) to extract the protein from 
inside the cell. Six cycles of 30 second sonification followed by a 30 
second cooling period were performed in a cold salt water bath. Cell 
debris was removed by centrifugation (4°C and 23000 g) for 30 min-
utes. The filtered supernatants were then adjusted to 10 units/ml by 
diluting them with a potassium phosphate buffer containing 2-mer-
captoethanol and magnesium chloride, pH 5.7 (Sigma Chemical, St. 
Louis, MO). 
Membrane Ion-Exchange Operation 
The adjusted cell extracts were passed through a microporous, ion-
exchange membrane enclosed in a polypropylene housing (Acti-
Disk ™Cartridge, FMC Corp., Rockland, ME). A matrix of quater-
nary amine came installed on the membrane to supply the fixed posi-
tive charge. Prior to loading the cartridge the membrane was equili-
brated by washing with 0.089M potassium phosphate buffer (0. lM 
ionic strength, pH 6). The wash was fed by a peristaltic pump at a 
flow rate of 2 ml/min for 10 minutes. Twelve milliliters of the cell 
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extract were prepared and a 2 ml sample of the feed was reserved. 
The remaining 10 ml were loaded onto the membrane, also at a rate 
of 2 ml/min. The apparatus assembly is pictured schematically in fig-
ure 2. 
After all of the feed was loaded onto the membrane, it was washed 
with 20 ml of the potassium phosphate buffer previously mentioned. 
The wash cleansed the membrane of any loosely-bound protein. 
Peristaltic 
Pump 
Sample 
Reservoir 
Effluent (UV Anaylsis) 
Fig. 2. Apparatus assembly with FMC QUAT. Courtesy of FMC 
Corporation, Pine Brook, NJ. 
Step Gradient Elution 
Following the wash, the protein was removed from the membrane 
by a series of elutions. Buffer solutions were prepared by adding sodi-
um chloride to the potassium phosphate wash buffer with ionic 
strengths ranging from 0.2 to 1.1 M. A step gradient elution was 
performed by injecting the buffers through the cartridge in 3 ml 
aliquots. By the time the 1.1 M solution was injected, nearly all of 
the protein was eluted. The individual effluents were analyzed for 
protein and activity content. 
Cartridge Storage 
The cartridge was sterilized by washing with a 25 ml sample each 
of deionized water and 70% methanol. The disk was dried by passing 
air through a syringe and stored at room temperature for reuse. 
Assays 
Protein content and activity assays were performed immediately 
afrer the step gradient elution. A dye-binding assay was performed to 
determine protein content and concentration. Coomassie Brilliant 
Blue G-250 stain (Bio-Rad, Richmond, CA) was used with a bovine 
serum albumin standard. Enzyme activity was monitored by a timed 
assay where o-nitrophenyl-f3-D-galactoside (ONPG), was hydrolyzed 
by the f3-galactosidase. One unit of activity is defined as the amount 
necessary to hydrolyze one micromole of ONPG to o-nitrophenol 
and galactose per minute at pH 7 .3 and 3 7°C. 
Recycle With Intermediate Partial Elution 
In later runs a recycle was implemented to increase the activity 
yield. The cartridge was prepared, loaded and washed as was done 
previously. At this point the membrane was eluted with 3 ml of the 
potassium phosphate salt solution via a syringe. The ionic strength of 
the elutant depended on the number of aspartates in the fusion tail. 
BGCDl was eluted with 0.2M solution, BGCD5 with 0.3M and 
0.4M for BGCDl 1. The increasing concentration reflected the 
increase in binding strength with tail length as discovered in our ini-
tial runs. With the membrane eluted, the feed was recycled and the 
cartridge was washed again with 20 ml of potassium phosphate 
buffer. The protein was then eluted through the step gradient proce-
dure as before. 
The purpose behind the partial elution was to remove any unde-
sired proteins and create additional space on the membrane surface 
for the successful binding of more f3-galactosidase. In addition, an 
accompanying reduction of undesired protein components in the 
final product would be favorable. 
RESULTS AND DISCUSSION 
The selectivity in this ion-exchange operation can occur either 
during the binding or release of the protein. Selectivity enhancement 
provided by the fusion tails was examined in both cases. 
Selective binding took place as a result of the intermediate partial 
elution. In this process the intermediate elution caused all loosely-
bound proteins to be eluted from the membrane. In addition, 
unwanted, neutral and positively charged ions were rinsed through. 
Hence, the membrane was cleaned and cleared in preparation for the 
reapplication of the feed during the recycle. 
The activity recovered in the effluent increased significantly with 
the recycle procedure. For example, an initial run ofBGCDl resulted 
in an activity recovery of 39 U/ml. In contrast, when the BGCDl 
feed was recycled, the activity recovered rose to 55 U/ml. Figure 3 
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Fig. 3. Activity recovery with intermediate elution and recycle proce-
dure. 
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shows the relationship between the increased activity and the inter-
mediate elution procedure. The first column of each set shows the 
amount of activity recovered without the recycle procedure and the 
second column corresponds to the amount of recovered activity with 
the feed recycled. Some of the activity was never recovered and may 
have been lost due to inactivation or remained bound to the mem-
brane during elution. Inactivation occurred when the enzyme was 
allowed to sit at room temperature for lengthy periods of time. In a 
measure to reduce the procedure time, the two, 20 ml buffer washes 
were performed using a syringe rather than the peristaltic pump. 
This step reduced the length of the recycle procedure and the assay 
results showed less missing activity. 
With the implementation of the intermediate partial elution recy-
cle procedure, an increase in product yield was seen when compared 
to the single pass procedure. More active 13-galactosidase was recov-
ered in the elutions than without the recycle. However, no increase in 
specific activity was seen for the recycled runs. 
Selective release was enhanced through the use of the step gradient 
elution. Each fusion showed a peak at the ionic strength Omax> 
required for eluting the fraction with the maximum specific activity. 
The Imax values remained quite reproducible throughout the bat-
tery of runs. An expected correlation between the fusion tail length 
and the Imax peak was soon proven; with the increase of aspartates in 
the tail the ionic strength required to release the protein increased. 
This can be attributed to the additional charge the aspartates provide 
to the fusion tails. 
Although protein was eluted throughout the gradient steps, at 
Imax the majority of the protein was washed off. Specific activity and 
purification factor peaks coincided with the Imax peaks; however, the 
maximum total protein concentration for all three fusions was eluted 
at 0.25 M. For BGCDl and the wild type enzyme, the peak came at 
0.3 M. BGCD5 showed a broader range spanning from 0.4 M to 0.5 
M with an Imax at 0.45 M. Similarly, BGCDl 1 had a broad peak, its 
maximum was at 0.55 M. An Imax value of0.3 M for commercial 13-
galactosidase shows that the purification fusion tails exhibit stronger 
binding. More information about the elution steps can be derived 
from figures 4, 5 and 6. The figures show the step gradient elution 
profiles for BGCDl, BGCD5 and BGCDll respectively. Protein 
concentration peaks can be seen at 0.25 M for all three tails. As seen 
in figure 4, the fraction with the maximum specific activity had a 
value of 350 U/mg. BGCD5 peaked at 400 U/ml and BGCDl at 
700 U/ml as shown in figures 5 and 6. 
To understand the level of enrichment each effluent sample had 
obtained, the purification factor was calculated. The purification fac-
tor a is defined as the total specific activity divided by the specific 
activity of the feed. The purification factor for BGCDl ranged from 
2.5 to 5 throughout the tests with an average of 4.0. As with specific 
activity, a increased with tail length. BGCD5 and an a of 4.5 and 
BGCD 11 an average a of 7 .0. Figure 7 shows a step gradient elution 
profile overlay with each fusion tail being represented. The different 
specific activity peaks have a direct correlation with the purification 
factor. Just as BGCDl 1 has the highest specific activity of the three 
tails, it too has the highest a. 
Throughout the testing, BGCDl 1 showed superior binding capa-
bilities far exceeding those seen for BGCDl and BGCD5. Its high 
specific activity brought upon by its longer tail led to a high purifica-
tion factor. The difference in specific activity and purification factor 
between BGCD5 and BGCDl 1 was substantially greater than that 
between BGCDl and BGCD5. It was hypothesized that more 
charges on the fusion tail yield stronger binding traits. Because 
BGCDl 1 bound to the membrane much stronger than either 
BGCDl or BGCD5, 11 aspartates in the tail could approach an opti-
mal number for selective binding. Continued research with even 
longer fusion tails would prove or disprove this hypothesis. 
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Fig. 4. Step gradient elution profile for BGCDl cell extracts treated 
using FMC QUAT. 
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Fig. 7. Specific activity peaks increase with longer tail length. The 
enzyme binds more strongly to the ion-exchange membrane with an 
increasing number of aspartates in the tail. 
CONCLUSIONS 
In this work it was demonstrated that purification fusion tails can 
be used to enhance separation and recovery on ion-exchange mem-
branes. Selective enhancement increased with fusion tail length. 
BGCDl 1 bound to the membrane most strongly followed by 
BGCDS and BGCDl. The bind and release process brought seven-
fold enrichment of BGCD 11 from cell extracts through step gradient 
elution. The product was recovered in an active state with a specific 
activity level comparable to commercial ~-galactosidase. The inter-
mediate partial elution procedure increased activity recovery by near-
ly 20%, however, no funher enrichment was witnessed. 
ACKNOWLEDGMENTS 
We are grateful to Dr. Charles Glatz for his guidance and helpful 
discussions in preparing this manuscript. This material is based upon 
work supported by the National Science Foundation under Grant 
No. BCS-9108583. 
REFERENCES 
1. FULTON S.P., A.J. SHAHID!, N.F. GORDON, and A.B. AFEYAN. 
1992. Large-Scale Processing and High-Throughout Perfusion Chrom-
atography. Bio/Techno!. 10:635-639. 
2. PARKER, D.E., C.E. GLATZ, C.F. FORD, S.M. GENDEL, I. SUOMI-
NEN, and M.A. ROUGVIE. 1990. Recovery of a Charge-fusion Protein 
from Cell Extracts by Polyelectrolyte Precipitation. Biotechno!. Bioeng. 
36:467-475. 
3. LUTHER, J.R. and C.E. GLATZ. Nov. 1990. Enhanced Partitioning in 
Aqueous Two-phase Systems Using Genetically Engineered 13-Galacto-
sidase. Poster presented at AIChE Annual Meeting, Chicago, IL. 
4. HENG, M.H. and C.E. GLATZ. 1993. Charged Fusions for the Selective 
Recovery of 13-Galactosidase from Cell Extracts Using Hollow Fiber Ion-
Exchange Membrane Adsorption. Biotechno!. Bioeng. 42:333-338. 
5. ZHAO,]., C.F. FORD, C.E. GLATZ, MA. ROUGVIE, and S.M. GEN-
DEL. 1990. Polyelectrolyte Precipitation of 13-Galactosidase Fusions 
Containing Polyaspartic Acid Tails.}. Biotechno!. 14:273-284. 
